Currentblue cross blue shield - louisianaPolicy 00960

Wound Care Supplies

Customize your policy alerts

Sign up for blue cross blue shield - louisiana Policy 00960 alerts

Get alerted when Policy 00960 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines coverage, medical necessity criteria, and usage guidance for wound care dressings and related supplies for members of Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.

Policy Summary

Payerblue cross blue shield - louisiana

PolicyWound Care Supplies

Policy CodePolicy 00960

Change TypeNo material changes

Effective DateJul 1, 2026

Last ReviewApr 1, 2027

Next Review DateApr 1, 2027

Key ActionDressing must be prescribed by a physician or wound specialist after evaluation with documentation of wound type/stage, drainage, size, dressing type/size/frequency/quantity and expected duration.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

manyHCPCS codes referenced

daily–weeklyFrequency guidance included

multipleTypes of dressings covered

1 monthMax dispense without documentation

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

Currentblue cross blue shield - louisianaPolicy 00960

Wound Care Supplies

Customize your policy alerts

Sign up for blue cross blue shield - louisiana Policy 00960 alerts

Get alerted when Policy 00960 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines coverage, medical necessity criteria, and usage guidance for wound care dressings and related supplies for members of Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.

Policy Summary

Payerblue cross blue shield - louisiana

PolicyWound Care Supplies

Policy CodePolicy 00960

Change TypeNo material changes

Effective DateJul 1, 2026

Last ReviewApr 1, 2027

Next Review DateApr 1, 2027

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

manyHCPCS codes referenced

daily–weeklyFrequency guidance included

multipleTypes of dressings covered

1 monthMax dispense without documentation

Not medically necessary lists

Coverage Criteria and Medical Necessity

Coverage criteria and restrictions

Wound care supplies are eligible when benefits permit and all medical necessity documentation and prescription requirements are met. Covered items, indications, sizing, frequencies, and supplier restrictions follow.

ALL of the following

Benefits must be available in the member's contract/certificate and medical necessity criteria and guidelines must be met.
Dressing must be prescribed by a physician or wound specialist after evaluation. Documentation must include type and stage of wound; presence of drainage, odor, new tissue growth, inflammation/wound color; location, number and size of wounds; and dressing classification (primary or secondary). Prescription must state dressing type, size appropriate to wound, frequency of change, number/amount to be used at one time, and expected duration.

ALL of the following

ANY of the following
- Indicated for moderately to highly exudative full-thickness wounds (e.g., Stage III–IV) and wound cavities; not indicated for dry wounds or wounds covered with eschar; do not combine with hydrogels.
- Frequency of change: once daily; size: one wound cover sheet approximating wound size or up to 2 units of wound filler.
ANY of the following
- Indicated for full-thickness wounds (e.g., Stage III–IV) with moderate to heavy exudate.
- As primary dressing: up to 3x/week; as secondary for very heavy exudate: up to 3x/week; as foam fillers: once per day.
ANY of the following
- Indicated for wounds with light to moderate exudate, including stalled wounds.
- Change up to 3x/week.
ANY of the following
- Medically necessary for full-thickness wounds with minimal or no exudate (Stage III–IV); medical necessity not established for Stage II ulcers; additional amounts beyond lining the wound surface or filling a cavity are not established; do not use more than one type of hydrogel dressing on the same wound at the same time.
- Hydrogel without adhesive border or hydrogel fillers: once daily.
ANY of the following
- For moderately or highly exudative full-thickness wounds (e.g., Stage III–IV).
- Without adhesive border: once daily; with adhesive border: every other day.
ANY of the following
- Open partial-thickness wounds with minimal exudate or closed wounds.
- Change up to 3x/week.
ANY of the following
- Waterproof collection device indicated for venous leg ulcers.
- Up to 3 dressing changes per week.
ANY of the following
- For treatment of venous leg ulcers.
- Weekly dressing change.
ANY of the following
- Medically necessary as primary or secondary dressing, e.g., for venous stasis; most are reusable.
- Change not more than once per week unless part of a multi-layer compression system. Gradient compression wrap limited to one per 6 months per leg.

ALL of the following

Use of more than one type of wound filler or more than one type of wound cover in a single wound is not reasonable and necessary, except when the primary dressing is either an alginate/fiber gelling dressing or a saline/water/hydrogel-impregnated gauze which may need an additional wound cover.
It is not appropriate to use a hydrating dressing and an absorptive dressing on the same wound simultaneously (e.g., hydrogel with alginate).
When combinations of primary, secondary dressings, and wound fillers are used, the change frequencies of individual products should be similar; the product in contact with the wound determines frequency. Combinations with differing change intervals (e.g., weekly secondary over daily primary) are not reasonable and may be denied.
A secondary dressing is not reasonable and necessary with primary dressings that contain an impervious backing layer with or without an adhesive border.

ALL of the following

Dressing/pad size must be appropriate to wound size; pad size usually about 2 inches greater than wound dimensions (example: 2 in. x 2 in. wound → 4 in. x 4 in. pad).
Quantity and type dispensed at one time must consider wound status, likelihood of change, and recent use. Suppliers must monitor actual use and adjust provision accordingly; suppliers must not dispense quantities exceeding expected utilization.
For recurring items, suppliers must have contact with the individual or caregiver and document an affirmative refill request prior to dispensing; items delivered without a valid documented refill request will be denied. Regardless of utilization, no more than a month's supply may be provided at one time unless documentation supports necessity of greater quantities.

ALL of the following

When surgical dressings are provided in kits, only components that meet the definition of a surgical dressing, that are ordered by the treating practitioner, and that are reasonable and necessary are covered.

Primary coverage criteria

Coverage and clinical criteria for surgical dressings and wound care supplies; these rules govern acceptable combinations, change-frequency alignment, sizing, and supplier dispensing.

ALL of the following

Use of more than one type of wound filler or more than one type of wound cover in a single wound is not reasonable and necessary. Exception: a primary dressing that is (1) an alginate or other fiber gelling dressing; or (2) a saline, water, or hydrogel-impregnated gauze dressing, which may require an additional wound cover.
Do not use a hydrating dressing on the same wound at the same time as an absorptive dressing (e.g., hydrogel and alginate).
When primary, secondary dressings, and wound filler are combined, the change frequencies should be similar; the product in contact with the wound determines frequency. Combinations with differing intervals are not reasonable and may be denied (e.g., weekly secondary over daily primary).
Secondary dressings are not reasonable and necessary with primary dressings that contain an impervious backing layer with or without an adhesive border.

Coding and Supply Quantity Guidance

HCPCS codes referencedHCPCS

A6196-A6199	Alginate/fiber dressings examples
A6010-A6024	Various dressings (examples listed)
A6203-A6266	Foam, hydrogel, hydrocolloid, fillers, transparent film, wound fillers and related codes
A6441-A6545	Compression, conforming, padding and gradient compression wrap codes
A6154	Wound pouch
A4450-A4452	Tape examples

Kit component coveragemixed

No codes listed

Tape quantity per dressing change

Tape quantity per dressing change16 sq in or less: up to 2 units; 16–48 sq in: up to 3 units; greater than 48 sq in: up to 4 units.

Change frequency determinationTape change is determined by the frequency of dressing change.

When tape not requiredNot required when a wound cover with an adhesive border is used; reasons for additional tape must be well documented.

Gradient compression wrap frequency

Gradient compression wrap frequency limitLimited to one per 6 months per leg.

IndicationUsed for treatment of venous stasis ulcer (A6545).

Documentation, Dispensing, and Utilization Requirements

Prior Authorization

Documentation and prescription required before dispensing

Dressing must be prescribed by a physician or wound specialist after examination/evaluation of the wound. Documentation must include type and stage of wound; presence of drainage, smell, new tissue growth and related findings such as inflammation and wound color; location, number, and size of wounds; and classification of dressing (primary or secondary). The prescription must state the type of dressing, size, frequency of dressing change, number/amount to be used at one time, and expected duration of need. Supplies are covered when prescribed and supplied by a home care agency with covered home health services or dispensed/used by a participating provider; items that do not require a prescription and can be purchased over-the-counter or given as take-home supplies are not covered.

Document wound type/stage, drainage, odor, new tissue growth, inflammation, and wound color.
Document wound location, number, and size, and whether dressing is primary or secondary.
Prescription must specify dressing type, size, change frequency, quantity per use, and expected duration.
Supplies not requiring a prescription or sold over-the-counter are not covered.

Definitions and Key Terms

Primary dressing

Primary dressing — definitionTherapeutic or protective covering applied directly to wounds or lesions either on the skin or caused by an opening to the skin.

PurposePlaced in direct contact with the wound to provide a therapeutic effect (e.g., absorptive, hydrating, protective).

Examples/roleMay include alginate, foam, hydrogel, hydrocolloid, transparent film and other dressings that contact the wound bed.

Secondary dressing

Secondary dressing — definitionMaterials that serve a therapeutic or protective function and that are needed to secure a primary dressing (e.g., adhesive tape, roll gauze, elastic bandages).

FunctionUsed to hold primary dressing in place, provide additional protection, or provide compression/support as indicated.

Policy Summary

Payerblue cross blue shield - louisiana

PolicyWound Care Supplies

Policy CodePolicy 00960

Change TypeNo material changes

Effective DateJul 1, 2026

Last ReviewApr 1, 2027

Next Review DateApr 1, 2027

SourceLink

On This Page

Dressing size must be appropriate to wound size; pad size usually approximately 2 inches greater than wound dimensions (example: 2x2 wound requires 4x4 pad).

ALL of the following

Suppliers must monitor actual use and adjust quantities accordingly; must verify changed or atypical utilization with the treating practitioner before dispensing additional supplies.
Suppliers must document an affirmative refill request and have contact with the individual or caregiver prior to dispensing recurring supplies. Items delivered without a valid documented refill request will be denied as not reasonable and necessary.
No more than a one-month supply may be dispensed at one time unless documentation supports the necessity of greater quantities in the home setting for an individual case.

Change frequency contextFrequency specified separately from other compression bandages which are generally not more than once per week unless part of a multi-layer system.

Maximum dispense at one time

Default maximum dispense at one timeNo more than a one month's supply of dressings may be provided at one time.

Exception to limitA greater quantity may be provided if documentation supports the necessity of greater quantities in the home setting for an individual case.

Supplier responsibilitySuppliers must monitor actual use and adjust quantities accordingly; quantities should reflect expected utilization.

Billing Rule

Require documented affirmative refill request; limit to 1 month supply

For recurring supplies, suppliers must have contact with the individual or caregiver and document an affirmative refill request prior to dispensing a new supply. Items delivered without a valid, documented refill request will be denied as not reasonable and necessary. Regardless of utilization, no more than a one month's supply of dressings may be provided at one time unless documentation supports greater quantities for the individual case.

Obtain and document an affirmative refill request from the member or caregiver before each refill.
Do not deliver refills without a documented refill request; such deliveries may be denied.
Limit dispensing to a maximum of one month's supply unless clinical documentation justifies more.

Denial Risk

Verify atypical or increased utilization with treating practitioner before dispensing

Suppliers must monitor actual use and verify with the treating practitioner any changed or atypical utilization before dispensing additional or atypical quantities. Quantities dispensed should not exceed an individual's expected utilization; items delivered without a valid documented refill request or without verification of atypical use may be denied as not reasonable and necessary.

Monitor client usage and adjust quantities to reflect wound status and likelihood of change.
Verify with the treating practitioner that atypical or increased utilization is warranted before dispensing.
Do not dispense quantities exceeding expected utilization or without verification/documentation.

When not neededNot reasonable/necessary when a wound cover with an adhesive border is used; additional tape or secondary dressing must be justified in documentation.

Medically Necessary

Medically Necessary — core definitionHealth care services, treatment, supplies, devices, or procedures that a Provider, exercising prudent clinical judgment, would provide to prevent, evaluate, diagnose, or treat an illness, injury, disease or its symptoms and that are in accordance with nationally accepted standards of medical practice.

Appropriateness criteriaMust be clinically appropriate in type, frequency, extent, level of care, site and duration and considered effective for the patient’s condition.

Cost and convenience considerationNot primarily for personal comfort or convenience of the patient or provider and not more costly than an alternative service at least as likely to produce equivalent therapeutic results.

Investigational

Investigational — core definitionA medical treatment, procedure, drug, device, or biological product is Investigational if its effectiveness has not been clearly tested and it has not been incorporated into standard medical practice.

Evidence considerationsDeterminations are based on FDA approval status, need for further studies or clinical trials, consultation with technology evaluation centers, and credible peer‑reviewed evidence.

Coverage implicationInvestigational items are not considered standard of care and are excluded from coverage under this policy unless approved by applicable authorities or supported by strong evidence.